Novonesis (Novozymes) B/ DK0060336014 /
07/11/2024 14:26:30 | Chg. -8.85 | Volume | Bid25/09/2024 | Ask06/11/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
418.55DKK | -2.07% | 401 Turnover: 166,143.50 |
-Bid Size: - | -Ask Size: - | 115.89 bill.DKK | 1.01% | 38.27 |
Assets
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 7,135 | 7,498 | 8,162 | 8,641 | 8,926 | ||||||
Intangible Assets | 2,864 | 2,954 | 2,676 | 1,578 | 2,432 | ||||||
Long-Term Investments | 14 | 29 | 139 | 151 | 29 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 1,902 | 2,184 | 2,281 | 2,488 | 2,586 | ||||||
Accounts Receivable | 2,242 | 2,244 | 2,558 | 2,680 | 2,554 | ||||||
Cash and Cash Equivalents | 1,003 | 2,535 | 839 | 812 | 632 | ||||||
Current Assets | 5,686 | 7,311 | 6,148 | 6,393 | 6,137 | ||||||
Total Assets | 16,506 | 18,426 | 17,791 | 18,659 | 18,373 |
Liabilities
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 976 | 1,122 | 1,189 | 1,194 | 1,341 | ||||||
Long-term debt | 1,734 | 1,242 | 1,216 | 1,727 | 1,312 | ||||||
Liabilities to Banks | 1,839 | 1,972 | 1,332 | 1,927 | 2,291 | ||||||
Provisions | 1,591 | 1,452 | 1,325 | 1,583 | 1,449 | ||||||
Liabilities | 5,440 | 7,146 | 6,198 | 6,914 | 7,106 | ||||||
Share Capital | 639 | 639 | 626 | 620 | 610 | ||||||
Total Equity | 11,054 | 11,269 | 11,580 | 11,732 | 11,254 | ||||||
Minority Interests | 12 | 11 | 13 | 13 | 13 | ||||||
Total liabilities equity | 16,506 | 18,426 | 17,791 | 18,659 | 18,373 |
Income Statement
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 11,746 | 12,459 | 14,002 | 14,142 | 14,531 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 2,901 | 3,384 | 3,884 | 3,946 | 4,047 | ||||||
Interest Income | -142 | -105 | -257 | -34 | -157 | ||||||
Income Before Taxes | 2,759 | 3,279 | 3,621 | 3,881 | 3,876 | ||||||
Income Taxes | 558 | 754 | 796 | 831 | 756 | ||||||
Minority Interests Profit | -1 | 1 | -2 | 0.0000 | -1 | ||||||
Net Income | 2,200 | 2,526 | 2,823 | 3,050 | 3,119 |
Per Share
Cash Flow
2013 IFRS in mill. DKK |
2014 IFRS in mill. DKK |
2015 IFRS in mill. DKK |
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 2,599 | 4,525 | 3,339 | 3,840 | 4,063 | ||||||
Cash Flow from Investing Activities | -1,423 | -310 | -1,257 | -1,349 | -1,668 | ||||||
Cash Flow from Financing | -532 | -2,703 | -3,681 | -2,484 | -2,815 | ||||||
Decrease / Increase in Cash | 612 | 1,511 | -1,657 | 9 | -442 | ||||||
Employees | 6,236 | 6,454 | 6,485 | 6,441 | 6,245 |